Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
Phase II Study Meets Primary Bone Mineral Density and Secondary Efficacy Endpoints Company to Host Conference Call and Webcast Wednesday, September 3rd at 8:30 am ET / 5:30 am PT SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Neurocrine Bios...invivodata Captures Symptom Relief Data in Endometriosis Trial
...econdary efficacy endpoint data in Neurocrine Biosciences' (Nasdaq: NBIX ) petal study, a Phase II clinical trial of its proprietary, orally-active nonpepti...htforward, and easily fit within our clinical development timeline." "The petal study represents an important step forward in Neurocrine's ongoing efforts ...Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis
...Analog Scale (VAS) are secondary endpoints. "The petal Study is an important trial for the elagolix progr...ed Dr. O'Brien. "The recruitment process for the petal Study confirms that endometriosis is an important,... phase topline data in early September 2008. The petal Study will contribute to the extensive data set of...Select roses survive with minimal care
... of rose varieties to assess their nutrient levels. Monthly recordings were also taken to rate each variety's disease resistance by noting symptoms of petal blight, powdery mildew, and black spot, some of the most common ailments of roses. Plants that were grown on their own roots had significantly better ...American Chemical Society's Weekly PressPac -- April 16, 2008
...IMMEDIATE RELEASE Chemists reproduce the roses petal effect Langmuir The lotus flower is natures ...angmuir, a bi-weekly journal, this newly described petal effect could lead to unique new adhesive materials...the design of biomimetic materials. But before the petal effect could be replicated in synthetic materials,...Neurocrine Biosciences Reports Second Quarter 2009 Results
...he Week 24 results of the recently completed Lilac petal Study (0702) were released earlier today. This stu... elagolix arms. These 24 Week results of the Lilac petal Study again confirmed that elagolix has clinically...with a favorable safety profile. The Tulip petal Study (0703) has completed subject randomization i...Neurocrine Biosciences Reports First Quarter 2009 Results
...riosis Elagolix for Endometriosis petal Study (NBI-56418-0603) The Company has recently completed the entire twelve months of the petal study, which included the post-treatment reviews t...ional clinical study for confirmation. Lilac petal Study (NBI-56418-0702) The Company recently re...